Altimmune, Inc. (ALT)
5.38
-0.14
(-2.54%)
USD |
NASDAQ |
Dec 10, 14:41
Altimmune Market Cap: 561.36M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 4.138B |
| Eli Lilly & Co. | 891.10B |
| Pfizer Inc. | 145.67B |
| Terns Pharmaceuticals, Inc. | 4.001B |
| Rhythm Pharmaceuticals, Inc. | 6.865B |
Market Cap Related Metrics
| PS Ratio | 21365.60 |
| Price to Book Value | 3.025 |
| Price | 5.38 |
| Earnings Yield | -19.87% |